Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sophie L Stocker

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
British Journal of Clinical Pharmacology|July 10, 2024
Economic evaluations of therapeutic drug monitoring interventions in acute hospital-based settings: A systematic reviewJane E Carland, David J Carland, Jonathan Brett, et al.
British Journal of Clinical Pharmacology|July 22, 2020
Would they trust it? An exploration of psychosocial and environmental factors affecting prescriber acceptance of computerised dose-recommendation softwareJane E Carland, Tania Elhage, Melissa T Baysari, et al.
Internal Medicine Journal|February 22, 2022
Pharmacogenomic testing: perception of clinical utility, enablers and barriers to adoption in Australian hospitalsAngela Pearce, Bronwyn Terrill, Jan-Willem Alffenaar, et al.
Journal of Nephrology|March 25, 2025
Dosing practices, pharmacokinetics, and effectiveness of allopurinol in gout patients receiving dialysis: a scoping reviewNoha A Kamel, Michael A Stokes, Daniel F B Wright, et al.
Therapeutic Drug Monitoring|October 4, 2022
Application of User-Centered Codesign Principles to Address Barriers in Therapeutic Drug MonitoringSherilyn Wong, Aaron Davis, Philip R Selby, et al.
Clinical Pharmacology and Therapeutics|July 31, 2025
The Type of Follicle-Stimulating Hormone Medication Given for In Vitro Fertilization Impacts Oocyte Retrieval: A Systematic Review and Meta-AnalysisToni J F Michael, Ranita Kirubakaran, Tanay Parab, et al.
British Journal of Clinical Pharmacology|February 4, 2012
The pharmacokinetics of oxypurinol in people with goutSophie L Stocker, Andrew J McLachlan, Radojka M Savic, et al.
Clinical Pharmacology and Therapeutics|September 30, 2020
A Model Averaging/Selection Approach Improves the Predictive Performance of Model-Informed Precision Dosing: Vancomycin as a Case StudyDavid W Uster, Sophie L Stocker, Jane E Carland, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 27, 2021
Current fluconazole treatment regimens result in under-dosing of critically ill adults during early therapyIndy Sandaradura, Deborah J E Marriott, Richard O Day, et al.
The Journal of Antimicrobial Chemotherapy|August 14, 2020
Assessing the accuracy of two Bayesian forecasting programs in estimating vancomycin drug exposureRashmi V Shingde, Stephanie E Reuter, Garry G Graham, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
British Journal of Clinical Pharmacology|July 10, 2024
Economic evaluations of therapeutic drug monitoring interventions in acute hospital-based settings: A systematic reviewJane E Carland, David J Carland, Jonathan Brett, et al.
British Journal of Clinical Pharmacology|July 22, 2020
Would they trust it? An exploration of psychosocial and environmental factors affecting prescriber acceptance of computerised dose-recommendation softwareJane E Carland, Tania Elhage, Melissa T Baysari, et al.
Internal Medicine Journal|February 22, 2022
Pharmacogenomic testing: perception of clinical utility, enablers and barriers to adoption in Australian hospitalsAngela Pearce, Bronwyn Terrill, Jan-Willem Alffenaar, et al.
Journal of Nephrology|March 25, 2025
Dosing practices, pharmacokinetics, and effectiveness of allopurinol in gout patients receiving dialysis: a scoping reviewNoha A Kamel, Michael A Stokes, Daniel F B Wright, et al.
Therapeutic Drug Monitoring|October 4, 2022
Application of User-Centered Codesign Principles to Address Barriers in Therapeutic Drug MonitoringSherilyn Wong, Aaron Davis, Philip R Selby, et al.
Clinical Pharmacology and Therapeutics|July 31, 2025
The Type of Follicle-Stimulating Hormone Medication Given for In Vitro Fertilization Impacts Oocyte Retrieval: A Systematic Review and Meta-AnalysisToni J F Michael, Ranita Kirubakaran, Tanay Parab, et al.
British Journal of Clinical Pharmacology|February 4, 2012
The pharmacokinetics of oxypurinol in people with goutSophie L Stocker, Andrew J McLachlan, Radojka M Savic, et al.
Clinical Pharmacology and Therapeutics|September 30, 2020
A Model Averaging/Selection Approach Improves the Predictive Performance of Model-Informed Precision Dosing: Vancomycin as a Case StudyDavid W Uster, Sophie L Stocker, Jane E Carland, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 27, 2021
Current fluconazole treatment regimens result in under-dosing of critically ill adults during early therapyIndy Sandaradura, Deborah J E Marriott, Richard O Day, et al.
The Journal of Antimicrobial Chemotherapy|August 14, 2020
Assessing the accuracy of two Bayesian forecasting programs in estimating vancomycin drug exposureRashmi V Shingde, Stephanie E Reuter, Garry G Graham, et al.
Pageof 10